The role of liquid perflubron (PFOB) in the oxidative process in vitro

Interaction with peroxyl radicals

Alexandre T. Rotta, Björn Gunnarsson, David M. Steinhorn

Research output: Contribution to journalArticle

Abstract

Introduction: Experimental models of acute lung injury treated with PFOB exhibit attenuation in tissue damage and inflammation. We have previously demonstrated an attenuation in oxidative injury to the lung in animals treated with PLV1. Since oxidative damage to tissues is preceded by the generation of reactive oxygen species, and peroxyl radicals cause oxidative injury, we hypothesized that PFOB might attenuate oxidative injury by acting as a scavenger for peroxyl radicals. Methods: We studied the in vitro peroxidation of alkali-activated dihydrochloro-fluorescein diacetate (DCFH-DA, 160 mM) in the absence (control, n=4) or presence of PFOB (PFOB, n=4). Various concentrations (25-50 mM) of AAPH, an azo-compound that generates peroxyl radicals during thermal decomposition, were used as the peroxyl radical source. The rate of peroxidation in the system was measured by kinetic spectrophotometry (O. D. 504 nm) as the colorless alkali-activated DCFH-DA is oxidized to the chromogen dichlorofluorescein (DCF). Results: Values are means ± SD for samples obtained from the aqueous phase, since DCF is not soluble in PFOB. Conclusions: PFOB does not act as a peroxyl radical scavenger, as the rate of oxidation of DCFH-DA to DCF is the same whether PFOB is present or absent. in the system. Thus, other mechanisms must be responsible for the decreased oxidative damage observed in vitro and in vivo.

Original languageEnglish (US)
JournalCritical Care Medicine
Volume27
Issue number1 SUPPL.
StatePublished - 1999
Externally publishedYes

Fingerprint

Alkalies
Reactive Oxygen Species
Azo Compounds
Acute Lung Injury
Spectrophotometry
Wounds and Injuries
Lung Injury
perhydroxyl radical
In Vitro Techniques
perflubron
Theoretical Models
Hot Temperature
Inflammation
diacetyldichlorofluorescein
3',6'-diacetylfluorescein
2,2'-azobis(2-amidinopropane)

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

The role of liquid perflubron (PFOB) in the oxidative process in vitro : Interaction with peroxyl radicals. / Rotta, Alexandre T.; Gunnarsson, Björn; Steinhorn, David M.

In: Critical Care Medicine, Vol. 27, No. 1 SUPPL., 1999.

Research output: Contribution to journalArticle

Rotta, Alexandre T. ; Gunnarsson, Björn ; Steinhorn, David M. / The role of liquid perflubron (PFOB) in the oxidative process in vitro : Interaction with peroxyl radicals. In: Critical Care Medicine. 1999 ; Vol. 27, No. 1 SUPPL.
@article{36ef7be301b6461089b9ab099554b5a5,
title = "The role of liquid perflubron (PFOB) in the oxidative process in vitro: Interaction with peroxyl radicals",
abstract = "Introduction: Experimental models of acute lung injury treated with PFOB exhibit attenuation in tissue damage and inflammation. We have previously demonstrated an attenuation in oxidative injury to the lung in animals treated with PLV1. Since oxidative damage to tissues is preceded by the generation of reactive oxygen species, and peroxyl radicals cause oxidative injury, we hypothesized that PFOB might attenuate oxidative injury by acting as a scavenger for peroxyl radicals. Methods: We studied the in vitro peroxidation of alkali-activated dihydrochloro-fluorescein diacetate (DCFH-DA, 160 mM) in the absence (control, n=4) or presence of PFOB (PFOB, n=4). Various concentrations (25-50 mM) of AAPH, an azo-compound that generates peroxyl radicals during thermal decomposition, were used as the peroxyl radical source. The rate of peroxidation in the system was measured by kinetic spectrophotometry (O. D. 504 nm) as the colorless alkali-activated DCFH-DA is oxidized to the chromogen dichlorofluorescein (DCF). Results: Values are means ± SD for samples obtained from the aqueous phase, since DCF is not soluble in PFOB. Conclusions: PFOB does not act as a peroxyl radical scavenger, as the rate of oxidation of DCFH-DA to DCF is the same whether PFOB is present or absent. in the system. Thus, other mechanisms must be responsible for the decreased oxidative damage observed in vitro and in vivo.",
author = "Rotta, {Alexandre T.} and Bj{\"o}rn Gunnarsson and Steinhorn, {David M.}",
year = "1999",
language = "English (US)",
volume = "27",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "1 SUPPL.",

}

TY - JOUR

T1 - The role of liquid perflubron (PFOB) in the oxidative process in vitro

T2 - Interaction with peroxyl radicals

AU - Rotta, Alexandre T.

AU - Gunnarsson, Björn

AU - Steinhorn, David M.

PY - 1999

Y1 - 1999

N2 - Introduction: Experimental models of acute lung injury treated with PFOB exhibit attenuation in tissue damage and inflammation. We have previously demonstrated an attenuation in oxidative injury to the lung in animals treated with PLV1. Since oxidative damage to tissues is preceded by the generation of reactive oxygen species, and peroxyl radicals cause oxidative injury, we hypothesized that PFOB might attenuate oxidative injury by acting as a scavenger for peroxyl radicals. Methods: We studied the in vitro peroxidation of alkali-activated dihydrochloro-fluorescein diacetate (DCFH-DA, 160 mM) in the absence (control, n=4) or presence of PFOB (PFOB, n=4). Various concentrations (25-50 mM) of AAPH, an azo-compound that generates peroxyl radicals during thermal decomposition, were used as the peroxyl radical source. The rate of peroxidation in the system was measured by kinetic spectrophotometry (O. D. 504 nm) as the colorless alkali-activated DCFH-DA is oxidized to the chromogen dichlorofluorescein (DCF). Results: Values are means ± SD for samples obtained from the aqueous phase, since DCF is not soluble in PFOB. Conclusions: PFOB does not act as a peroxyl radical scavenger, as the rate of oxidation of DCFH-DA to DCF is the same whether PFOB is present or absent. in the system. Thus, other mechanisms must be responsible for the decreased oxidative damage observed in vitro and in vivo.

AB - Introduction: Experimental models of acute lung injury treated with PFOB exhibit attenuation in tissue damage and inflammation. We have previously demonstrated an attenuation in oxidative injury to the lung in animals treated with PLV1. Since oxidative damage to tissues is preceded by the generation of reactive oxygen species, and peroxyl radicals cause oxidative injury, we hypothesized that PFOB might attenuate oxidative injury by acting as a scavenger for peroxyl radicals. Methods: We studied the in vitro peroxidation of alkali-activated dihydrochloro-fluorescein diacetate (DCFH-DA, 160 mM) in the absence (control, n=4) or presence of PFOB (PFOB, n=4). Various concentrations (25-50 mM) of AAPH, an azo-compound that generates peroxyl radicals during thermal decomposition, were used as the peroxyl radical source. The rate of peroxidation in the system was measured by kinetic spectrophotometry (O. D. 504 nm) as the colorless alkali-activated DCFH-DA is oxidized to the chromogen dichlorofluorescein (DCF). Results: Values are means ± SD for samples obtained from the aqueous phase, since DCF is not soluble in PFOB. Conclusions: PFOB does not act as a peroxyl radical scavenger, as the rate of oxidation of DCFH-DA to DCF is the same whether PFOB is present or absent. in the system. Thus, other mechanisms must be responsible for the decreased oxidative damage observed in vitro and in vivo.

UR - http://www.scopus.com/inward/record.url?scp=33750812726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750812726&partnerID=8YFLogxK

M3 - Article

VL - 27

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 1 SUPPL.

ER -